AL-LAD Dosage Guide

## Overdose Profile There are **no documented fatal overdoses** attributed to AL-LAD in the published medical or forensic toxicology literature. This is consistent with the broader safety profile of classical lysergamides, which as a class exhibit an **extremely high therapeutic index** --- meaning the ratio between an effective dose and a lethal dose is very large. ### Physiological Risk LSD, the most extensively studied lysergamide, has an estimated LD50 in humans that is orders of magnitude above typical recreational doses. While AL-LAD-specific LD50 data has not been determined (due to its status as a research chemical without formal clinical trials), its close structural and pharmacological relationship to LSD suggests a similarly wide margin of safety with respect to acute physiological toxicity [1]. The primary risks of AL-LAD overconsumption are **psychological rather than physical**: - **Overwhelming perceptual distortion** and loss of contact with reality - **Acute anxiety, panic, or paranoia** ("bad trip") - **Temporary psychotic-like states** including delusions, confusion, and disorganized behavior - **Risky behavior** resulting from impaired judgment during intense effects ### Management Individuals experiencing a difficult AL-LAD experience should be placed in a calm, low-stimulation environment with reassurance from a trusted companion. In clinical settings, **benzodiazepines** (e.g., diazepam, lorazepam) are the standard intervention for severe psychedelic-induced agitation or anxiety. Antipsychotics with 5-HT2A antagonist activity (e.g., olanzapine) can also terminate the psychedelic state [2]. ## References [1] Passie T, et al. The pharmacology of lysergic acid diethylamide: a review. CNS Neurosci Ther. 2008;14(4):295-314. [2] Nichols DE. Psychedelics. Pharmacol Rev. 2016;68(2):264-355.